Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Rapamycin Is a Potent Inhibitor of Skin Tumor Promotion by 12-O-Tetradecanoylphorbol-13-Acetate

Cancer Prev Res (Phila) (2011) 4 (7): 1011–1020.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Limosomes versus hyalurolimosomes loaded with piperine for management of skin cancer
  • Sally A. El-Zahaby
  • Sherien A. Abdelhady
  • Mennatallah A. Ali
  • Sameh E. Younis
  • Yosra S.R. Elnaggar
International Journal of Pharmaceutics (2024) 650: 123730.
Cancer prevention with rapamycin
  • Mikhail V. Blagosklonny
Oncotarget (2023) 14 (1): 342.
White adipose tissue-derived factors and prostate cancer progression: mechanisms and targets for interventions
  • Achinto Saha
  • Jill Hamilton-Reeves
  • John DiGiovanni
Cancer and Metastasis Reviews (2022) 41 (3): 649.
Autophagy in Cisplatin Nephrotoxicity during Cancer Therapy
  • Xiaoru Hu
  • Zhengwei Ma
  • Lu Wen
  • Siyao Li
  • Zheng Dong
Cancers (2021) 13 (22): 5618.
Persistent activation of the mammalian target of rapamycin signalling pathway in cutaneous squamous cell carcinomas in cats
  • Berenice L. Sanz Ressel
  • Adriana R. Massone
  • Claudio G. Barbeito
Veterinary Dermatology (2021) 32 (6): 675.
Rapamycin Extends Life Span in Apc Colon Cancer FAP Model
  • Manish Parihar
  • Sherry G. Dodds
  • Gene Hubbard
  • Martin A. Javors
  • Randy Strong
  • Paul Hasty
  • Zelton Dave Sharp
Clinical Colorectal Cancer (2021) 20 (1): e61.
AMPK Inhibits mTOR-Driven Keratinocyte Proliferation after Skin Damage and Stress
  • Elizabeth D. Crane
  • Wesley Wong
  • Hui Zhang
  • Gerard O’Neil
  • Justin D. Crane
Journal of Investigative Dermatology (2021) 141 (9): 2170.
Combination use of tolfenamic acid with curcumin improves anti‐inflammatory activity and reduces toxicity in mice
  • Wei Zhou
  • Qifa Liu
  • Xiaohao Zang
  • Mengmeng Hu
  • Yuan Yue
  • Yuchu Wang
  • Chunyan Lv
  • Zhiyun Du
Journal of Food Biochemistry (2020) 44 (6)
Advances on Natural Polyphenols as Anticancer Agents for Skin Cancer
  • Soraya Sajadimajd
  • Roodabeh Bahramsoltani
  • Amin Iranpanah
  • Jayanta Kumar Patra
  • Gitishree Das
  • Sushanto Gouda
  • Roja Rahimi
  • Elnaz Rezaeiamiri
  • Hui Cao
  • Francesca Giampieri
  • Maurizio Battino
  • Rosa Tundis
  • Maria G. Campos
  • Mohammad Hosein Farzaei
  • Jianbo Xiao
Pharmacological Research (2020) 151: 104584.
Calcium Fructoborate Prevents Skin Cancer Development in Balb-c Mice
  • Mehmet Ali Kisacam
  • Gonca Ozan Kocamuftuoglu
  • Ibrahim Enver Ozan
  • Mehmet Yaman
  • Sema Temizer Ozan
Biological Trace Element Research (2020) 196 (1): 131.
Dysregulated Expression of Phosphorylated Epidermal Growth Factor Receptor and Phosphatase and Tensin Homologue in Canine Cutaneous Papillomas and Squamous Cell Carcinomas
  • B.L. Sanz Ressel
  • A.R. Massone
  • C.G. Barbeito
Journal of Comparative Pathology (2020) 174: 26.
Immunohistochemical expression of selected phosphoproteins of the mTOR signalling pathway in canine cutaneous squamous cell carcinoma
  • B.L. Sanz Ressel
  • A.R. Massone
  • C.G. Barbeito
The Veterinary Journal (2019) 245: 41.
Dysregulated expression of the key effectors of the mammalian target of rapamycin signalling pathway in cutaneous papillomas of dogs
  • Berenice L. Sanz Ressel
  • Adriana R. Massone
  • Claudio G. Barbeito
Veterinary and Comparative Oncology (2019) 17 (4): 522.
Inhibition of skin tumor promotion by TPA using a combination of topically applied ursolic acid and curcumin
  • Lisa Tremmel
  • Okkyung Rho
  • Thomas J. Slaga
  • John DiGiovanni
Molecular Carcinogenesis (2019) 58 (2): 185.
Rapamycin Modulates Glucocorticoid Receptor Function, Blocks Atrophogene REDD1, and Protects Skin from Steroid Atrophy
  • Ekaterina Lesovaya
  • Shivani Agarwal
  • Ben Readhead
  • Elena Vinokour
  • Gleb Baida
  • Pankaj Bhalla
  • Kirill Kirsanov
  • Marianna Yakubovskaya
  • Leonidas C. Platanias
  • Joel T. Dudley
  • Irina Budunova
Journal of Investigative Dermatology (2018) 138 (9): 1935.
Translating Mechanism-Based Strategies to Break the Obesity−Cancer Link: A Narrative Review
  • Laura A. Smith
  • Ciara H. O’Flanagan
  • Laura W. Bowers
  • Emma H. Allott
  • Stephen D. Hursting
Journal of the Academy of Nutrition and Dietetics (2018) 118 (4): 652.
While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblasts
  • Olga V. Leontieva
  • Mikhail V. Blagosklonny
Oncotarget (2017) 8 (65): 109848.
Anti‐aging pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and rapamycin by local application
  • Pan Zhao
  • Bing‐Dong Sui
  • Nu Liu
  • Ya‐Jie Lv
  • Chen‐Xi Zheng
  • Yong‐Bo Lu
  • Wen‐Tao Huang
  • Cui‐Hong Zhou
  • Ji Chen
  • Dan‐Lin Pang
  • Dong‐Dong Fei
  • Kun Xuan
  • Cheng‐Hu Hu
  • Yan Jin
Aging Cell (2017) 16 (5): 1083.
Molecular signaling cascades involved in nonmelanoma skin carcinogenesis
  • Robert P. Feehan
  • Lisa M. Shantz
Biochemical Journal (2016) 473 (19): 2973.
Inhibition of Akt Enhances the Chemopreventive Effects of Topical Rapamycin in Mouse Skin
  • Sally E. Dickinson
  • Jaroslav Janda
  • Jane Criswell
  • Karen Blohm-Mangone
  • Erik R. Olson
  • Zhonglin Liu
  • Christy Barber
  • Emanuel F. Petricoin
  • Valerie S. Calvert
  • Janine Einspahr
  • Jesse E. Dickinson
  • Steven P. Stratton
  • Clara Curiel-Lewandrowski
  • Kathylynn Saboda
  • Chengcheng Hu
  • Ann M. Bode
  • Zigang Dong
  • David S. Alberts
  • G. Timothy Bowden
Cancer Prevention Research (2016) 9 (3): 215.
Overexpression of PRAS40T246A in the Proliferative Compartment Suppresses mTORC1 Signaling, Keratinocyte Migration, and Skin Tumor Development
  • Okkyung Rho
  • Jaya Srivastava
  • Jiyoon Cho
  • John DiGiovanni
Journal of Investigative Dermatology (2016) 136 (10): 2070.
Negative regulation of the FOXO3a transcription factor by mTORC2 induces a pro-survival response following exposure to ultraviolet-B irradiation
  • Robert P. Feehan
  • Lisa M. Shantz
Cellular Signalling (2016) 28 (8): 798.
Immune-Stimulatory Effects of Rapamycin Are Mediated by Stimulation of Antitumor γδ T Cells
  • Vinh Dao
  • Yang Liu
  • Srilakshmi Pandeswara
  • Robert S. Svatek
  • Jonathan A. Gelfond
  • Aijie Liu
  • Vincent Hurez
  • Tyler J. Curiel
Cancer Research (2016) 76 (20): 5970.
mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model
  • Juan Luis Callejas-Valera
  • Ramiro Iglesias-Bartolome
  • Panomwat Amornphimoltham
  • Julia Palacios-Garcia
  • Daniel Martin
  • Joseph A. Califano
  • Alfredo A. Molinolo
  • J.Silvio Gutkind
Carcinogenesis (2016) 37 (10): 1014.
Conditional disruption of rictor demonstrates a direct requirement for mTORC2 in skin tumor development and continued growth of established tumors
  • Theresa D. Carr
  • Robert P. Feehan
  • Michael N. Hall
  • Markus A. Rüegg
  • Lisa M. Shantz
Carcinogenesis (2015) 36 (4): 487.
Synergism between mTORpathway and ultraviolet radiation in the pathogenesis of squamous cell carcinoma and its implication for solid‐organ transplant recipients
  • Yevgeniy Balagula
  • Sewon Kang
  • Manisha J. Patel
Photodermatology, Photoimmunology & Photomedicine (2015) 31 (1): 15.
Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice
  • Helga Weber
  • Pamela Leal
  • Stefan Stein
  • Hana Kunkel
  • Patricia García
  • Carolina Bizama
  • Jaime A. Espinoza
  • Ismael Riquelme
  • Bruno Nervi
  • Juan C. Araya
  • Manuel Grez
  • Juan C. Roa
Oncotarget (2015) 6 (31): 31877.
A weighty problem: metabolic perturbations and the obesity-cancer link
  • Ciara H. O’Flanagan
  • Laura W. Bowers
  • Stephen D. Hursting
Hormone Molecular Biology and Clinical Investigation (2015) 23 (2): 47.
REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids
  • Gleb Baida
  • Pankaj Bhalla
  • Kirill Kirsanov
  • Ekaterina Lesovaya
  • Marianna Yakubovskaya
  • Kit Yuen
  • Shuchi Guo
  • Robert M Lavker
  • Ben Readhead
  • Joel T Dudley
  • Irina Budunova
EMBO Molecular Medicine (2015) 7 (1): 42.
Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology
  • Alexander L. Fogel
  • Sharleen Hill
  • Joyce M.C. Teng
Journal of the American Academy of Dermatology (2015) 72 (5): 879.
Evaluation of pentacyclic triterpenes found inPerilla frutescensfor inhibition of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate
  • Jiyoon Cho
  • Lisa Tremmel
  • Okkyung Rho
  • Andrew M. Camelio
  • Dionicio Siegel
  • Thomas J. Slaga
  • John DiGiovanni
Oncotarget (2015) 6 (36): 39292.
Effect of Combined Treatment with Ursolic Acid and Resveratrol on Skin Tumor Promotion by 12-O-Tetradecanoylphorbol-13-Acetate
  • Jiyoon Cho
  • Okkyung Rho
  • Jacob Junco
  • Steve Carbajal
  • Dionicio Siegel
  • Thomas J. Slaga
  • John DiGiovanni
Cancer Prevention Research (2015) 8 (9): 817.
Prevention of Carcinogen and Inflammation-Induced Dermal Cancer by Oral Rapamycin Includes Reducing Genetic Damage
  • Vinh Dao
  • Srilakshmi Pandeswara
  • Yang Liu
  • Vincent Hurez
  • Sherry Dodds
  • Danielle Callaway
  • Aijie Liu
  • Paul Hasty
  • Zelton D. Sharp
  • Tyler J. Curiel
Cancer Prevention Research (2015) 8 (5): 400.
A novel mechanism of skin tumor promotion involving interferon‐gamma (IFNγ)/signal transducer and activator of transcription‐1 (Stat1) signaling
  • Ronald Bozeman
  • Erika L. Abel
  • Everardo Macias
  • Tianyi Cheng
  • Linda Beltran
  • John DiGiovanni
Molecular Carcinogenesis (2015) 54 (8): 642.
p53 and rapamycin are additive
  • Barbara Christy
  • Marco Demaria
  • Judith Campisi
  • Jing Huang
  • Diane Jones
  • Sherry G. Dodds
  • Charnae Williams
  • Gene Hubbard
  • Carolina B. Livi
  • Xiaoli Gao
  • Susan Weintraub
  • Tyler Curiel
  • Z. Dave Sharp
  • Paul Hasty
Oncotarget (2015) 6 (18): 15802.
Effect of Metformin, Rapamycin, and Their Combination on Growth and Progression of Prostate Tumors in HiMyc Mice
  • Achinto Saha
  • Jorge Blando
  • Lisa Tremmel
  • John DiGiovanni
Cancer Prevention Research (2015) 8 (7): 597.
Impact of mTORC1 inhibition on keratinocyte proliferation during skin tumor promotion in wild‐type and BK5.AktWT mice
  • Okkyung Rho
  • Kaoru Kiguchi
  • Guiyu Jiang
  • John DiGiovanni
Molecular Carcinogenesis (2014) 53 (11): 871.
Metformin Inhibits Skin Tumor Promotion in Overweight and Obese Mice
  • L. Allyson Checkley
  • Okkyung Rho
  • Joe M. Angel
  • Jiyoon Cho
  • Jorge Blando
  • Linda Beltran
  • Stephen D. Hursting
  • John DiGiovanni
Cancer Prevention Research (2014) 7 (1): 54.
Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion
  • Olga V. Leontieva
  • Mikhail V. Blagosklonny
Oncotarget (2014) 5 (24): 12715.
Immunosuppressants in cancer prevention and therapy
  • Mikhail V Blagosklonny
OncoImmunology (2013) 2 (12): e26961.
Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair
  • Christiane Kuschal
  • Kai‐Martin Thoms
  • Steffen Schubert
  • Annika Schäfer
  • Lars Boeckmann
  • Michael P. Schön
  • Steffen Emmert
Experimental Dermatology (2012) 21 (1): 2.
Rapalogs in cancer prevention
  • Mikhail V. Blagosklonny
Cancer Biology & Therapy (2012) 13 (14): 1349.
Obesity, Energy Balance, and Cancer: New Opportunities for Prevention
  • Stephen D. Hursting
  • John DiGiovanni
  • Andrew J. Dannenberg
  • Maria Azrad
  • Derek LeRoith
  • Wendy Demark-Wahnefried
  • Madhuri Kakarala
  • Angela Brodie
  • Nathan A. Berger
Cancer Prevention Research (2012) 5 (11): 1260.
Functional Protein Pathway Activation Mapping of the Progression of Normal Skin to Squamous Cell Carcinoma
  • Janine G. Einspahr
  • Valerie Calvert
  • David S. Alberts
  • Clara Curiel-Lewandrowski
  • James Warneke
  • Robert Krouse
  • Steven P. Stratton
  • Lance Liotta
  • Caterina Longo
  • Giovanni Pellicani
  • Anil Prasad
  • Paul Sagerman
  • Yira Bermudez
  • Jianghong Deng
  • G. Timothy Bowden
  • Emanuel F. Petricoin
Cancer Prevention Research (2012) 5 (3): 403.
Metformin, an Antidiabetic Agent Reduces Growth of Cutaneous Squamous Cell Carcinoma by Targeting mTOR Signaling Pathway†
  • Sandeep C. Chaudhary
  • Deepali Kurundkar
  • Craig A. Elmets
  • Levy Kopelovich
  • Mohammad Athar
Photochemistry and Photobiology (2012) 88 (5): 1149.
Dose‐dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin‐like growth factor‐1
  • Leticia M. Nogueira
  • Jackie A. Lavigne
  • Gadisetti V. R. Chandramouli
  • Huaitian Lui
  • J. Carl Barrett
  • Stephen D. Hursting
Cancer Medicine (2012) 1 (2): 275.
Inhibition of mTOR Suppresses UVB-Induced Keratinocyte Proliferation and Survival
  • Theresa D. Carr
  • John DiGiovanni
  • Christopher J. Lynch
  • Lisa M. Shantz
Cancer Prevention Research (2012) 5 (12): 1394.
Exploiting the origins of Ras mediated squamous cell carcinoma to develop novel therapeutic interventions
  • Andrew C. White
  • William E. Lowry
Small GTPases (2011) 2 (6): 318.
Rapamycin and mTORC1 Inhibition in the Mouse: Skin Cancer Prevention
  • Mohammad Athar
  • Levy Kopelovich
Cancer Prevention Research (2011) 4 (7): 957.
Antitumorigenic Effect of a High Protein Diet in Mouse Skin
  • Ka-Hee Tak
  • Eun-Jung Kim
Preventive Nutrition and Food Science (2011) 16 (4): 283.
  • Online ISSN 1940-6215
  • Print ISSN 1940-6207

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept